Sidewinder Therapeutics

Sidewinder TherapeuticsSidewinder Therapeutics
ST

Sidewinder Therapeutics

Pioneering next-generation bispecific ADCs for cancer treatment.

Website
2026Active9San Diego, USA
Rate
Advertise here

About

Sidewinder Therapeutics is pioneering the next generation of bispecific antibody-drug conjugates (ADCs) designed to expand the therapeutic window for patients with difficult-to-treat cancers. Their engineered ADCs target receptor co-complexes highly expressed on solid tumors, aiming for enhanced tumor cell specificity and internalization. The company is built by a team of entrepreneurs, scientists, and drug developers committed to delivering these advanced therapies.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Sidewinder Therapeutics do?

Sidewinder Therapeutics is pioneering the next generation of bispecific antibody-drug conjugates (ADCs) designed to expand the therapeutic window for patients with difficult-to-treat cancers. Their engineered ADCs target receptor co-complexes highly expressed on solid tumors, aiming for enhanced tumor cell specificity and internalization. The company is built by a team of entrepreneurs, scientists, and drug developers committed to delivering these advanced therapies.

How much funding has Sidewinder Therapeutics raised?

Sidewinder Therapeutics has raised a total of $137M in funding. The most recent round on record is Series B.

Where is Sidewinder Therapeutics headquartered?

Sidewinder Therapeutics is headquartered in San Diego, California, USA.

When was Sidewinder Therapeutics founded?

Sidewinder Therapeutics was founded in 2026.

What industry does Sidewinder Therapeutics operate in?

Sidewinder Therapeutics operates in Biotechnology, Pharmaceuticals, Oncology, Drug Discovery.

How many employees does Sidewinder Therapeutics have?

Sidewinder Therapeutics has approximately 9 people on record.

What is Sidewinder Therapeutics's revenue?

StartupHub estimates Sidewinder Therapeutics's annual revenue at $925K (range $531K to $2.8M, 70% confidence), based on comparable companies in the sector.

What is Sidewinder Therapeutics's valuation?

StartupHub estimates Sidewinder Therapeutics's effective valuation at $523.3M (range $342.5M to $822.0M, 24% confidence), based on comparable companies in the sector.